drugset / Trial / NCT07444424

A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants

NCT07444424

Phase 1 Completed 32 enrolled AstraZeneca Parexel · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to assess the effect of AZD5004 on the pharmacokinetics (PK) of mitiglinide and pioglitazone in healthy participants.

Timeline

Start
2026-03-13
Primary completion
2026-07-02
Completion
2026-07-02

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD5004 Unknown Oral
Subject Mitiglinide Small molecule Oral
Subject Pioglitazone Small molecule Oral

Indications

No indication recorded.